Track topics on Twitter Track topics that are important to you
The Hong Kong Polytechnic University (PolyU) is celebrating its 80th Anniversary this year with a Global Leader Lecture Series in which influential leaders in different professions around the globe will be invited to PolyU to deliver lectures on a wide range of topics covering healthcare, business, innovation and entrepreneurship, art and culture, sports and sustainable urban development.
Hong Kong (PRWEB) February 17, 2017
The Hong Kong Polytechnic University (PolyU) is celebrating its 80th Anniversary this year with a Global Leader Lecture Series in which influential leaders in different professions around the globe will be invited to PolyU to deliver lectures on a wide range of topics covering healthcare, business, innovation and entrepreneurship, art and culture, sports and sustainable urban development. The series will provide the university community with a unique opportunity to learn from the stimulating insights and fresh perspectives of the speakers, and help inspire students to dream big and to bring positive changes to the world.
Kicking off the series, the Faculties of Applied Science and Textiles (FAST) and Health and Social Sciences (FHSS) of PolyU had the honour of having Dr Marie-Paule Kieny, Assistant Director-General, Health Systems and Innovation, of the World Health Organization (WHO) to present a lecture entitled “Vaccine Development during the Ebola Public Health Emergency: Lessons Learnt and Perspectives for Enhanced Preparedness” which took place on 15th February.
Ebola hemorrhagic fever was first described in 1976. The most widespread Ebola outbreak on record began in Guinea in December 2013, infecting more than 28,000 and killing over 11,300 people in many countries including Guinea, Liberia and Sierra Leone by 2016. In the absence of vaccines, and with insufficient diagnostics and medical teams, WHO led the development of an effective vaccine, demonstrating the possibility of compressing the research and development (R&D) time needed from a decade or longer to less than one year. During 2015-2016, Dr Kieny played a leading role in WHO's Ebola research activities by developing and evaluating innovative antiviral drugs and vaccines. She is currently in charge of Zika Virus R&D in WHO as well as the preparation of a WHO R&D Blueprint to accelerate global research preparedness for future outbreaks. The challenges and obstacles that global public health agencies face when devising a rapid response to control emerging infectious diseases was the highlight of Dr Kieny’s lecture.
Professor Timothy W. Tong, President of PolyU, said, “At PolyU, our scholars and scientists have been focusing on research that can improve public health. We have active research programmes in drug development, vaccine studies, infection control and food safety……We have also been collaborating with the World Health Organization to exchange views and expertise on various health issues.”
Through the PolyU 80th Anniversary Global Leader Lecture Series, PolyU promotes knowledge sharing by bringing global leaders to inspire us, and in this lecture, by sharing innovative R&D processes needed to control public health emergencies like the Ebola outbreak.
For further information, please visit http://www.polyu.edu.hk/fast/80anniversary/who/.
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/02/prweb14080154.htmNEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...